- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- February 2025
- 90 Pages
Europe
From €2367EUR$2,490USD£1,989GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- October 2023
- 145 Pages
Global
From €2995EUR$3,150USD£2,516GBP
- Report
- January 2024
- 353 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- February 2023
- 86 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Book
- December 2019
- 1800 Pages
The Breast Biopsy Device market is a segment of the Medical Devices industry that focuses on the development and sale of devices used to perform biopsies on the breast. These devices are used to diagnose and treat breast cancer and other breast diseases. They typically include a needle, a vacuum, and a cutting device. The needle is used to extract tissue samples from the breast, the vacuum is used to collect the tissue samples, and the cutting device is used to cut the tissue samples into smaller pieces.
The Breast Biopsy Device market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Hologic, Becton Dickinson, C.R. Bard, Cook Medical, and Olympus. These companies offer a range of products, from manual biopsy devices to automated systems. Additionally, many of these companies have developed specialized products for specific applications, such as ultrasound-guided biopsies. Show Less Read more